AVBC vs RARE · rev $130.6M vs rev $350.0M
Avidia Bancorp, Inc. (AVBC) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Avidia Bancorp, Inc. (AVBC) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AVBC revenue for 2025-12-31 was $130.6M. Net income was -$3.3M. Revenue was up 5.5% from 2024-12-31 to 2025-12-31. AVBC currently screens at market cap $0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AVBC currently screens at market cap $0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AVBC and RARE stock pages for the full models.
Not investment advice.